FDA Approves New Drug to Prevent RSV in Babies and Toddlers
Today, the U.S. Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates …
A new immunization hinted at an end to bad RSV seasons. But an ... - CNN
Dec 5, 2023 · On November 16, the CDC and FDA announced that they had expedited the availability of 77,000 additional 100-mg doses of Beyfortus and that these would go to …
Beyfortus approved in the US for the prevention of RSV lower ...
Jul 17, 2023 · AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in …
There’s a new shot to protect newborns from a serious ... - CNN
Oct 5, 2023 · The new shot, which goes by the brand name Beyfortus, slashed infants’ risk of being hospitalized for RSV by 80% in clinical trials. It promised to be a game-changer for the …
Press Room - Sanofi US News
Updated as of October 26, 2023. There has been unprecedented demand for Beyfortus™ (nirsevimab-alip). For the first time in history, health care providers are able to help protect an …
Sanofi shipping BEYFORTUS® in US to help protect ... - news…
Sep 16, 2024 · BEYFORTUS is the first and only long-acting monoclonal antibody approved for the prevention of RSV lower respiratory tract disease (LRTD) in newborns and infants born …
More doses of new RSV immunization for babies are on the way ... - CNN
Dec 14, 2023 · CNN — More hard-to-find doses of Beyfortus, the new immunization against respiratory syncytial virus (RSV) for infants, will be available in January, the White House …
FDA approves nirsevimab to prevent RSV in infants
Jul 17, 2023 · The monoclonal antibody nirsevimab (brand name Beyfortus) was approved as a single injection for infants born during or entering their first RSV season and young children up …
Press Room - Sanofi US News
Jul 17, 2023 · Beyfortus™ is the first monoclonal antibody approved to protect all infants through their first RSV season. Across all clinical endpoints, a single dose of Beyfortus delivered high, …
Beyfortus® immunization to protect infants from RSV has begun
Oct 28, 2024 · Beyfortus ® is the first immunization designed for all infants to help prevent RSV lower respiratory tract disease through their first RSV season. Beyfortus ® is also indicated for …
- Some results have been removed